Antibody-drug conjugates: new drugs – new toxicities

This comprehensive review discusses the toxicity profile of available ADC treatments for solid tumors and outlines practical approaches for toxicity monitoring and management. As the future of ADC therapy continues to evolve, integrating proactive toxicity mitigation and supportive care into clinical practice is crucial for maximizing therapeutic effect while also preserving patients' quality of life.